2023 - Research.com Neuroscience in Australia Leader Award
His primary areas of study are Internal medicine, Endocrinology, Neuroscience, Neuropeptide and Relaxin-3. His Internal medicine research integrates issues from Neuron and In situ hybridization. His Endocrinology research is multidisciplinary, incorporating perspectives in Molecular biology, Hyperesthesia and Myoclonic Jerk.
His Neuropeptide study combines topics in areas such as Amygdala, Nucleus and Anxiety. Andrew L. Gundlach has researched Relaxin-3 in several fields, including Elevated plus maze, Open field and Anxiolytic. His Nucleus Incertus study incorporates themes from Forebrain and Dorsal raphe nucleus.
His scientific interests lie mostly in Internal medicine, Endocrinology, Relaxin-3, Neuroscience and Receptor. His work investigates the relationship between Internal medicine and topics such as Neuron that intersect with problems in Orexin. His Endocrinology study combines topics from a wide range of disciplines, such as Neuropeptide, Galanin and In situ hybridization.
His work is dedicated to discovering how Relaxin-3, Tegmentum are connected with GABAergic and other disciplines. His Neuroscience study frequently draws connections to adjacent fields such as Nucleus Incertus. His studies in Receptor integrate themes in fields like Endogeny, Stereochemistry and Peptide.
His primary scientific interests are in Relaxin-3, Neuroscience, Internal medicine, Endocrinology and Neuropeptide. His Relaxin-3 study is concerned with the field of Receptor as a whole. Many of his studies on Neuroscience apply to Nucleus Incertus as well.
His work on Paraventricular nucleus of hypothalamus, Anxiogenic, Lateral hypothalamus and Pars compacta as part of general Internal medicine research is frequently linked to Modulation, bridging the gap between disciplines. His Endocrinology research includes elements of Neuron and Melanin-concentrating hormone. His Neuropeptide research includes themes of Oxytocin, Solitary nucleus and Cell biology.
The scientist’s investigation covers issues in Neuroscience, Relaxin-3, Arousal, Receptor and Internal medicine. Andrew L. Gundlach interconnects Monoamine neurotransmitter, Orexin and Nucleus Incertus in the investigation of issues within Neuroscience. The concepts of his Relaxin-3 study are interwoven with issues in Tegmentum and Neuron.
His Tegmentum study integrates concerns from other disciplines, such as Gene knockdown, Agonist, Relaxin, Choline acetyltransferase and MAPK/ERK pathway. As part of his studies on Internal medicine, he frequently links adjacent subjects like Endocrinology. The Neuropeptide study combines topics in areas such as Hypothalamus, Oxytocin and Inhibitory postsynaptic potential.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1- propyl)piperidine
AL Gundlach;BL Largent;SH Snyder.
The Journal of Neuroscience (1986)
Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
B L Largent;A L Gundlach;S H Snyder.
Journal of Pharmacology and Experimental Therapeutics (1986)
The galanin peptide family: receptor pharmacology, pleiotropic biological actions, and implications in health and disease.
Roland Lang;Andrew L. Gundlach;Barbara Kofler.
Pharmacology & Therapeutics (2007)
Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine.
Brian L. Largent;Andrew L. Gundlach;Solomon H. Snyder.
Proceedings of the National Academy of Sciences of the United States of America (1984)
Physiology, Signaling, and Pharmacology of Galanin Peptides and Receptors: Three Decades of Emerging Diversity
Roland Lang;Andrew L. Gundlach;Fiona E. Holmes;Sally A. Hobson.
Pharmacological Reviews (2015)
Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner
Stanislaw Mitew;Ilan Gobius;Laura R. Fenlon;Stuart J. McDougall.
Nature Communications (2018)
Restricted, but abundant, expression of the novel rat gene-3 (R3) relaxin in the dorsal tegmental region of brain.
Tanya C. D. Burazin;Ross A. D. Bathgate;Mary Macris;Sharon Layfield.
Journal of Neurochemistry (2002)
Relaxin-3 in GABA projection neurons of nucleus incertus suggests widespread influence on forebrain circuits via G-protein-coupled receptor-135 in the rat
Sherie Ma;Pascal Bonaventure;Tania Ferraro;Pei-Juan Shen.
Localization of 3H‐Dihydroergotamine‐binding sites in the cat central nervous system: Relevance to migraine
Peter J. Goadsby;Andrew L. Gundlach.
Annals of Neurology (1991)
Galanin/GALP and galanin receptors: role in central control of feeding, body weight/obesity and reproduction?
Andrew L Gundlach.
European Journal of Pharmacology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: